908 Devices Inc. (NASDAQ:MASS) Shares Purchased by Barclays PLC

Barclays PLC boosted its stake in shares of 908 Devices Inc. (NASDAQ:MASS) by 452.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 46,214 shares of the company’s stock after acquiring an additional 37,853 shares during the quarter. Barclays PLC owned about 0.13% of 908 Devices worth $160,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of MASS. SG Americas Securities LLC purchased a new stake in shares of 908 Devices during the third quarter worth approximately $36,000. Drive Wealth Management LLC purchased a new position in 908 Devices during the 3rd quarter worth $50,000. Townsquare Capital LLC purchased a new position in 908 Devices during the 3rd quarter worth $50,000. 49 Wealth Management LLC lifted its stake in shares of 908 Devices by 16.2% in the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after acquiring an additional 4,343 shares during the period. Finally, American Century Companies Inc. boosted its holdings in shares of 908 Devices by 18.6% in the second quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock valued at $174,000 after acquiring an additional 5,295 shares in the last quarter. 88.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MASS. Leerink Partners reissued a “market perform” rating and set a $4.00 price target (down from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Stifel Nicolaus cut their target price on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Finally, Leerink Partnrs downgraded 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

908 Devices Trading Down 3.2 %

MASS stock opened at $2.13 on Wednesday. The company’s 50-day moving average price is $2.54 and its 200 day moving average price is $3.64. 908 Devices Inc. has a 52 week low of $1.81 and a 52 week high of $9.10. The company has a market cap of $74.17 million, a P/E ratio of -1.20 and a beta of 0.96.

908 Devices Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.